Basically, next to a few small studies dealing with various haptens (summarized in Table 1), there are two major episodes in the history of immunotherapy of ACD: one devoted to searching for cure ...

lysozyme or haptens 3. Whether B cells that carry a specific receptor for self-antigens in the lymphohematopoietic system or in the periphery do exist or are deleted (negatively selected against ...

The adjuvant is nontoxic and works with all tested types of antigens: proteins, glycoproteins, peptides and haptens conjugated to a carrier. Figure 1: mRNA expression for different cytokines ...

Researchers from Purdue University and Eradivir Inc. presented a newly developed bispecific small molecule (zanDR) that bound and inhibited influenza neuraminidase on both free virus and ...

Differentiating between ICD and ACD is often difficult in the clinical setting, thus misleading the physician with respect to cause and preventative strategy. The diagnosis of CD depends on ...